Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 15, 2009, Pages 4067-4069

  Gajewski, Mariusz P ^a   Beall, Howard ^a   Schnieder, Mark ^a   Stranahan, Sarah M ^b   Mosher, Michael D ^b,c   Rider, Kevin C ^a,b   Natale, Nicholas R ^a,b  

^a UNIVERSITY OF MONTANA   (United States)

^b UNIVERSITY OF IDAHO   (United States)

^c UNIVERSITY OF NEBRASKA AT KEARNEY   (United States)

Author keywords

Anthracene; Antitumor; Fluorescence; G quadruplex DNA; Glioma; Isoxazole; SNB 19

Indexed keywords

ANTINEOPLASTIC AGENT; BIS ANTHRACENYL ISOXAZOLYL AMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG MECHANISM; DRUG PURIFICATION; DRUG STRUCTURE; FLUORESCENCE; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY;

AMIDES; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DIMERIZATION; DNA; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOMA; HUMANS; HYDROGEN-ION CONCENTRATION; MODELS, CHEMICAL; MOLECULAR CONFORMATION;

EID: 67649990310     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.06.019     Document Type: Article

References (18)

1. Han X., Li C., Mosher M.D., Rider K.C., Zhou P., Crawford R.L., Fusco W., Paszczynski A., and Natale N.R. Bioorg. Med. Chem. 17 (2009) 1671-1680
2. For a preliminary communication, see:. Zhou P., Mosher M.D., Taylor W.D., Crawford G.A., and Natale N.R. Bioorg. Med. Chem. Lett. 7 (1997) 2455-2456
3. Boyd M.R. Princ. Pract. Oncol. 3 (1989) 1-12
4. Monchaud D., and Teulade-Fichou M.-P. Org. Biomol. Chem. 6 (2008) 627-636
5. De Cian A., Lacroix L., Douarre C., Temime-Smaali N., Trentesaux C., Riou J.-L., and Mergny J.-F. Biochimie 90 (2008) 131-155
6. Xu Y., Noguchi Y., and Sugiyama H. Bioorg. Med. Chem. 14 (2006) 5584-5591
7. Zhang N., Phan A.T., and Patel D.J. J. Am. Chem. Soc. 127 (2005) 17277-17285
8. Siddiqui-Jain A., Grand C.L., Bearss D.J., and Hurley L.H. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 11593-11598
9. Bollini M., Casal J.J., and Bruno A.M. Bioorg. Med. Chem. 16 (2008) 8003-8010
10. Basha A., Lipton M., and Weinreb S.M. Tetrahedron Lett. (1977) 4171-4174
11. Lipton M.F., Basha A., and Weinreb S.M. Org. Synth. 59 (1979) 49-53
12. Nishiwaki E., Tanaka S., Lee H., and Shibuya M. Heterocycles 27 (1988) 1945-1952
13. Han X., Twamley B., and Natale N.R. J. Heterocycl. Chem. 40 (2003) 539-545
14. Ross J.B.A., Laws W.R., and Shea M. In: Unversky V.N., and Permyakov E.A. (Eds). Intrinsic Fluorescence in Protein Structure Analysis in Protein Structures: Methods in Protein Structure and Structure Analysis (2007), Nova Science, New York
15. Sharmin A., Minazzo A., Salassa L., Rosenberg E., Ross J.B.A., Shariff S.E., and Hardcastle K.I. Inorg. Chim Acta 361 (2008) 1624-1633
16. 2: 784.2457, found 784.2436. 2.7 ppm.
17. 2: 957.2683, found 957.2708. 2.7 ppm.
18. 2: 1028.3418, found 1028.3414. 0.4 ppm.